105 related articles for article (PubMed ID: 22588912)
1. [Serum miR-103 as a potential diagnostic biomarker for breast cancer].
Wang X; Wu X; Yan L; Shao J
Nan Fang Yi Ke Da Xue Xue Bao; 2012 May; 32(5):631-4. PubMed ID: 22588912
[TBL] [Abstract][Full Text] [Related]
2. Decreased serum miR-181a is a potential new tool for breast cancer screening.
Guo LJ; Zhang QY
Int J Mol Med; 2012 Sep; 30(3):680-6. PubMed ID: 22692639
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-21 as an indicator of aggressive phenotype in breast cancer.
Ozgün A; Karagoz B; Bilgi O; Tuncel T; Baloglu H; Kandemir EG
Onkologie; 2013; 36(3):115-8. PubMed ID: 23485999
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of miR-106b expression in breast cancer patients.
Zheng R; Pan L; Gao J; Ye X; Chen L; Zhang X; Tang W; Zheng W
J Surg Res; 2015 May; 195(1):158-65. PubMed ID: 25619461
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer.
Liu H; Zhu L; Liu B; Yang L; Meng X; Zhang W; Ma Y; Xiao H
Cancer Lett; 2012 Mar; 316(2):196-203. PubMed ID: 22169097
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patients.
Kumar S; Keerthana R; Pazhanimuthu A; Perumal P
Indian J Biochem Biophys; 2013 Jun; 50(3):210-4. PubMed ID: 23898484
[TBL] [Abstract][Full Text] [Related]
7. Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma.
Zhao A; Li G; Péoc'h M; Genin C; Gigante M
Exp Mol Pathol; 2013 Feb; 94(1):115-20. PubMed ID: 23064048
[TBL] [Abstract][Full Text] [Related]
8. Expression level of miR-93 in formalin-fixed paraffin-embedded tissues of breast cancer patients.
Deng ZQ; Qian J; Liu FQ; Lin J; Shao R; Yin JY; Tang Q; Zhang M; He L
Genet Test Mol Biomarkers; 2014 May; 18(5):366-70. PubMed ID: 24606013
[TBL] [Abstract][Full Text] [Related]
9. [Expression of plasma miR-106a in colorectal cancer and its clinical significance].
Zhang L; Meng L; Fan Z; Liu B; Pei Y; Zhao Z
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Mar; 34(3):354-7. PubMed ID: 24670448
[TBL] [Abstract][Full Text] [Related]
10. Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma.
Fang C; Zhu DX; Dong HJ; Zhou ZJ; Wang YH; Liu L; Fan L; Miao KR; Liu P; Xu W; Li JY
Ann Hematol; 2012 Apr; 91(4):553-9. PubMed ID: 21987025
[TBL] [Abstract][Full Text] [Related]
11. Basic fibroblast growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: useful as diagnostic tools?
Granato AM; Nanni O; Falcini F; Folli S; Mosconi G; De Paola F; Medri L; Amadori D; Volpi A
Breast Cancer Res; 2004; 6(1):R38-45. PubMed ID: 14680499
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer.
Wang ZX; Bian HB; Wang JR; Cheng ZX; Wang KM; De W
J Surg Oncol; 2011 Dec; 104(7):847-51. PubMed ID: 21721011
[TBL] [Abstract][Full Text] [Related]
13. Analysis of serum genome-wide microRNAs for breast cancer detection.
Wu Q; Wang C; Lu Z; Guo L; Ge Q
Clin Chim Acta; 2012 Jul; 413(13-14):1058-65. PubMed ID: 22387599
[TBL] [Abstract][Full Text] [Related]
14. Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma.
Iwamoto H; Kanda Y; Sejima T; Osaki M; Okada F; Takenaka A
Int J Oncol; 2014 Jan; 44(1):53-8. PubMed ID: 24212760
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.
Xu J; Wu C; Che X; Wang L; Yu D; Zhang T; Huang L; Li H; Tan W; Wang C; Lin D
Mol Carcinog; 2011 Feb; 50(2):136-42. PubMed ID: 21229610
[TBL] [Abstract][Full Text] [Related]
16. The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma.
Zhang T; Wang Q; Zhao D; Cui Y; Cao B; Guo L; Lu SH
Clin Sci (Lond); 2011 Nov; 121(10):437-47. PubMed ID: 21658006
[TBL] [Abstract][Full Text] [Related]
17. Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma.
Hauser S; Wulfken LM; Holdenrieder S; Moritz R; Ohlmann CH; Jung V; Becker F; Herrmann E; Walgenbach-Brünagel G; von Ruecker A; Müller SC; Ellinger J
Cancer Epidemiol; 2012 Aug; 36(4):391-4. PubMed ID: 22542158
[TBL] [Abstract][Full Text] [Related]
18. Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls.
Hu Z; Dong J; Wang LE; Ma H; Liu J; Zhao Y; Tang J; Chen X; Dai J; Wei Q; Zhang C; Shen H
Carcinogenesis; 2012 Apr; 33(4):828-34. PubMed ID: 22298638
[TBL] [Abstract][Full Text] [Related]
19. Circulating miR-34a levels are reduced in colorectal cancer.
Nugent M; Miller N; Kerin MJ
J Surg Oncol; 2012 Dec; 106(8):947-52. PubMed ID: 22648208
[TBL] [Abstract][Full Text] [Related]
20. Prediction of breast tumor progression by integrity of free circulating DNA in serum.
Umetani N; Giuliano AE; Hiramatsu SH; Amersi F; Nakagawa T; Martino S; Hoon DS
J Clin Oncol; 2006 Sep; 24(26):4270-6. PubMed ID: 16963729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
